CAN

CANN GROUP FPO [CAN]
Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe. Its product portfolio includes the Satipharm delivery system for cannabinoids. The company was founded in 2014 and is based in Mildura, Australia.
Healthcare · ASX Small Cap
$0.0050 +0.0%

Updated 9 Sep 2026 · Signals refresh every scan

⚠ Funding Risk — Cash runway under 4 quarters. Capital raise or funding may be required.
Appeared in 2 consecutive scansFirst seen: 2026-02-25
Get alerts when CAN triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track CAN — Free

Active Signals

Bullish Signals

  • Trading above both moving averages — the trend is your friend here
  • Volume surging at 8.2x normal while price falls — heavy selling pressure
  • Beating the Small Ords index — relative strength of 1.71, so it's outpacing the pack
  • Critical cash runway (1.5 quarters)
  • 4C filed 2026-07-29
  • Low P/S ratio (0.9x)
  • Revenue in sharp decline (-24%)
  • EPS estimates revised upward (+10pts)
  • Near 52-week low (14% of range)
  • Micro-cap ($5-20M) - high risk
  • Strong return on equity (154%)
  • Healthy profit margins (210%)
  • Sentiment is mixed — no strong consensus either way
  • This one has been in freefall — down 73% over the past year
  • Altman Z-Score distress zone (0.14 < 1.81, low-confidence approx)
  • Penny stock risk ($0.005)
  • RBA hiking (-3pts)

Risk Signals

  • RSI is running hot — overbought territory, so expect some pullback risk
  • Below the 200-day average — the long-term trend is still working against it
  • Piotroski F-Score weak (3/9, low-confidence approx)
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • Revenue declining at -24% — the top line is shrinking

Recent Catalysts

NONE FY26 Results
NONE Preliminary Final Report
NONE Change of Auditor
LOW Quarterly Activities/Appendix 4C Cash Flow Report

Recent ASX Announcements

2026-08-31 FY26 Results PRICE SENSITIVE
2026-08-31 Preliminary Final Report PRICE SENSITIVE
2026-07-29 Quarterly Activities/Appendix 4C Cash Flow Report PRICE SENSITIVE
2026-07-13 Change of Auditor

Key Metrics

$8.3M
Market Cap
3.8M
Avg Volume
8.2x
Vol Ratio
$0.00 — $0.02
52-Week Range
N/A
Short Interest
2 qtrs
Cash Runway
154.5%
ROE
210.4%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSneutralEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 91%
LLeader vs LaggardpassRS: 15
IInstitutional SponsorshipweakInst: 4%
MMarket DirectionneutralNeutral

Sector: Healthcare

110 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
NUZ +37.1%IPD +20.0%HIQ +16.7%AVE +15.0%CVB +11.1%
Compare:CAN vs NUZCAN vs IPDCAN vs HIQ
Share this analysis

Track CAN and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required